top of page
Asset 3_4x-8.png

Democratizing Advanced Fertility

NAYA Fertility, formed through the merger of NAYA Biosciences and INVO Bioscience, aims to address rapidly expanding demand and limited accessibility in the fertility market.

Screenshot 2023-11-06 at 17.02.43.png

INVOcell® is our novel, FDA-cleared and CE-marked IVC device. It offers a viable alternative to IVF that uses the female body for fertilization and incubation, keeping women at the center of the reproductive process. This unique method allows us to reduce costs, increase accessibility, and improve the patient experience.

Screenshot 2023-11-09 at 16.04.31.png
Screenshot 2023-11-10 at 12.36.57.png

INVOcell® is suitable for a majority of patients and has demonstrated comparable success rates to IVF at a fraction of the cost.

The first two INVO Centers have been established in Atlanta, GA and Birmingham, AL, and INVO has recently acquired the Wisconsin Fertility Institute, voted one of America's best fertility clinics in 2023 by Newsweek.  

NAYA Fertility aims to both accelerate the commercialization of INVOcell® and expand the growing network of INVO clinics, democratizing access to advanced options and allowing more patients the chance to create the families they dream of. 

bottom of page